These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 6765080)
1. [Incidence of Candida sp. in patients undergoing kidney transplants]. Ghezzi MC; Giordano A; Cipriani P; Brenciaglia MI Ann Ist Super Sanita; 1982; 18(3):481-3. PubMed ID: 6765080 [No Abstract] [Full Text] [Related]
2. A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp. Diekema DJ; Messer SA; Hollis RJ; Boyken L; Tendolkar S; Kroeger J; Jones RN; Pfaller MA Diagn Microbiol Infect Dis; 2009 Feb; 63(2):233-6. PubMed ID: 19070452 [TBL] [Abstract][Full Text] [Related]
3. [The analysis of the phenotypic characters of candida fungi isolated from the patients]. Tyczkowska-Sieroń E Wiad Parazytol; 2005; 51(2):173-4. PubMed ID: 16838631 [No Abstract] [Full Text] [Related]
4. Yeast from burn patients at a major burn centre of China. Luo G; Peng Y; Yuan Z; Cheng W; Wu J; Fitzgerald M Burns; 2011 Mar; 37(2):299-303. PubMed ID: 20434270 [TBL] [Abstract][Full Text] [Related]
5. [Changes in epidemiology of opportunistic infections due to Candida]. Odds FC Rev Clin Esp; 1995 Oct; 195 Suppl 3():1-3. PubMed ID: 9441300 [No Abstract] [Full Text] [Related]
6. Comparative antifungal activity of hamycin against candida strains complicating tuberculosis. Panse MV; Narayan RA Hindustan Antibiot Bull; 1973 Aug; 16(1):25-8. PubMed ID: 4544912 [No Abstract] [Full Text] [Related]
7. Trends in antifungal use and species distribution among Candida isolates in a large paediatric hospital. Manno G; Scaramuccia A; Rossi R; Coppini A; Cruciani M Int J Antimicrob Agents; 2004 Dec; 24(6):627-8. PubMed ID: 15555894 [No Abstract] [Full Text] [Related]
8. Rapid determination of fluconazole susceptibilities for clinical specimens with possible polymicrobial Candida spp. Chiew YF; Inwood H N Z Med J; 2007 Jun; 120(1255):U2567. PubMed ID: 17546112 [No Abstract] [Full Text] [Related]
9. Antifungal susceptibility of 1000 Candida bloodstream isolates to 5 antifungal drugs: results of a multicenter study conducted in São Paulo, Brazil, 1995-2003. da Matta DA; de Almeida LP; Machado AM; Azevedo AC; Kusano EJ; Travassos NF; Salomão R; Colombo AL Diagn Microbiol Infect Dis; 2007 Apr; 57(4):399-404. PubMed ID: 17240110 [TBL] [Abstract][Full Text] [Related]
10. Detection and antifungal susceptibility testing of oral Candida dubliniensis from human immunodeficiency virus-infected patients. Chunchanur SK; Nadgir SD; Halesh LH; Patil BS; Kausar Y; Chandrasekhar MR Indian J Pathol Microbiol; 2009; 52(4):501-4. PubMed ID: 19805956 [TBL] [Abstract][Full Text] [Related]
11. In vitro interaction of micafungin and fluconazole against Candida. Rodríguez MM; Ruiz M; Pastor FJ; Quindós G; Carrillo A; Guarro J J Antimicrob Chemother; 2007 Jul; 60(1):188-90. PubMed ID: 17525050 [No Abstract] [Full Text] [Related]
12. Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features. Kim MN; Shin JH; Sung H; Lee K; Kim EC; Ryoo N; Lee JS; Jung SI; Park KH; Kee SJ; Kim SH; Shin MG; Suh SP; Ryang DW Clin Infect Dis; 2009 Mar; 48(6):e57-61. PubMed ID: 19193113 [TBL] [Abstract][Full Text] [Related]
13. In vitro antifungal susceptibility of clinical isolates of Candida spp. obtained from patients with different predisposing factors to candidosis. Pinto PM; Weikert-Oliveira Rde C; Lyon JP; Cury VF; Arantes RR; Koga-Ito CY; Resende MA Microbiol Res; 2008; 163(5):579-85. PubMed ID: 16962755 [TBL] [Abstract][Full Text] [Related]
14. [Epidemiological study of invasive nosocomial candidiasis in 2 teaching hospitals in Beijing]. Cao B; Wang H; Wu L; Sun WJ; Li F; Liu YM Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1970-3. PubMed ID: 19062737 [TBL] [Abstract][Full Text] [Related]
15. Epidemiology of candida bloodstream infections in a tertiary care institute in India. Kothari A; Sagar V Indian J Med Microbiol; 2009; 27(2):171-2. PubMed ID: 19384050 [No Abstract] [Full Text] [Related]
16. Prevalence of Candida species in different hospital wards and their susceptibility to antifungal agents: results of a three year survey. Fadda ME; Podda GS; Pisano MB; Deplano M; Cosentino S J Prev Med Hyg; 2008 Jun; 49(2):69-74. PubMed ID: 18847180 [TBL] [Abstract][Full Text] [Related]
17. In vitro activity of voriconazole against Candida species isolated in Taiwan. Yang YL; Cheng HH; Lo HJ Int J Antimicrob Agents; 2004 Sep; 24(3):294-6. PubMed ID: 15325436 [TBL] [Abstract][Full Text] [Related]
18. The effects of new nystatin and polyfungin derivatives as compared to original antibiotics on Candida strains isolated from patients with recurrent mycoses. Kwaśniewska J Mater Med Pol; 1988; 20(4):233-7. PubMed ID: 3249541 [No Abstract] [Full Text] [Related]
19. Update on clinical antifungal susceptibility testing for Candida species. Lewis RE; Klepser ME; Pfaller MA Pharmacotherapy; 1998; 18(3):509-15. PubMed ID: 9620102 [TBL] [Abstract][Full Text] [Related]